FinnCap reissued their corporate rating on shares of Tristel (LON:TSTL) in a report released on Monday, ThisIsMoney.Co.Uk reports.
Tristel stock opened at GBX 456.90 ($6.01) on Monday. The business has a 50 day moving average of GBX 400.14 and a 200-day moving average of GBX 336.75. Tristel has a 1 year low of GBX 260 ($3.42) and a 1 year high of GBX 460 ($6.05). The company has a market capitalization of $203.90 million and a P/E ratio of 51.34.
Tristel (LON:TSTL) last released its quarterly earnings data on Monday, February 24th. The company reported GBX 5.37 ($0.07) earnings per share (EPS) for the quarter. As a group, equities research analysts predict that Tristel will post 1199.9999883 EPS for the current fiscal year.
In other Tristel news, insider Paul Martin Barnes sold 15,000 shares of the stock in a transaction that occurred on Monday, February 24th. The shares were sold at an average price of GBX 422 ($5.55), for a total transaction of £63,300 ($83,267.56).
Tristel Company Profile
Tristel Plc develops, manufactures, and supplies infection and contamination control, and hygiene products in the United Kingdom, Germany, and internationally. The company operates through three segments: Human Healthcare, Animal Healthcare, and Contamination Control. It offers hospital infection prevention and control products under the Tristel brand; contamination control products for pharmaceutical and personal care industries under the Crystel brand; and animal health infection prevention and control products under the Anistel brand.
Recommended Story: Balanced Fund
Receive News & Ratings for Tristel Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tristel and related companies with MarketBeat.com's FREE daily email newsletter.